BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND ATF1, TREB36, 466, ENSG00000123268, P18846 AND Prognosis
9 results:

  • 1. Serum squamous cell carcinoma antigen level and magnetic resonance imaging for the prognosis of locally advanced cervical cancer.
    Gu LN; Yu JW; Jiang L; Liu TB; Xu Y
    Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):668-678. PubMed ID: 38305609
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts.
    Fremond S; Andani S; Barkey Wolf J; Dijkstra J; Melsbach S; Jobsen JJ; Brinkhuis M; Roothaan S; Jurgenliemk-Schulz I; Lutgens LCHW; Nout RA; van der Steen-Banasik EM; de Boer SM; Powell ME; Singh N; Mileshkin LR; Mackay HJ; Leary A; Nijman HW; Smit VTHBM; Creutzberg CL; Horeweg N; Koelzer VH; Bosse T
    Lancet Digit Health; 2023 Feb; 5(2):e71-e82. PubMed ID: 36496303
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Long non-coding RNA RP11-552M11.4 favors tumorigenesis and development of cervical cancer via modulating miR-3941/atf1 signaling.
    Xu Y; Zhou W; Zhang C; Liu X; Lv J; Li X; Zhao L; Li W; Li J; Ren Y; Ou R
    Int J Biol Macromol; 2019 Jun; 130():24-33. PubMed ID: 30790638
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Evaluation of 18F-FDG PET/CT parameters for reflection of aggressiveness and prediction of prognosis in early-stage cervical cancer.
    Zhang L; Sun H; Du S; Xu W; Xin J; Guo Q
    Nucl Med Commun; 2018 Nov; 39(11):1045-1052. PubMed ID: 30204642
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.
    Lee HJ; Lee JJ; Park JY; Kim JH; Kim YM; Kim YT; Nam JH
    J Gynecol Oncol; 2017 Jul; 28(4):e43. PubMed ID: 28541634
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Endometrioid endometrial cancer--the prognostic value of selected clinical and pathological parameters].
    Gottwald L; Chałubińska J; Moszyńska-Zielińska M; Piekarski J; Tyliński W; Szwalski J; Kubiak R; Pasz-Walczak G; Hendzel K; Ciałkowska-Rysz A
    Ginekol Pol; 2011 Oct; 82(10):743-8. PubMed ID: 22379937
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Elevated plasma growth differentiation factor-15 correlates with lymph node metastases and poor survival in endometrial cancer.
    Staff AC; Trovik J; Eriksson AG; Wik E; Wollert KC; Kempf T; Salvesen HB
    Clin Cancer Res; 2011 Jul; 17(14):4825-33. PubMed ID: 21616994
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology.
    Tsinzerling N; Lefvert AK; Matell G; Pirskanen-Matell R
    J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1109-12. PubMed ID: 17353257
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. p53CM1 expression is not associated with prognosis in uterine cervical carcinoma.
    Oka K; Nakano T; Arai T
    Cancer; 1993 Jul; 72(1):160-4. PubMed ID: 8508400
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.